J. MOLNER |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14 EUR | -1.41% |
|
-2.78% | +1.82% |
More news
| 1 day | -1.41% | ||
| 1 week | -2.78% | ||
| Current month | -7.28% | ||
| 1 month | -6.67% | ||
| 3 months | -10.26% | ||
| 6 months | +30.23% | ||
| Current year | +1.82% |
1 week
14.00
14.60
1 month
10.8015.10
Current year
10.8018.00
1 year
5.1018.00
3 years
5.0018.00
5 years
5.0018.00
10 years
5.0018.00
JMolner AS is an Estonia-based company primarily engaged in generic drug development for specialty generic pharmaceuticals. The Company also provides analytical chemistry services and cost-saving commercial stability solutions. The Company's main focus is on the USA and Canadian markets, however it also provides its laboratory analytics services to local Estonian and European customers.
Sector
Pharmaceuticals
Calendar
2024-08-04
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +1.82% | 25.94M | |
| +18.71% | 44.35B | |
| +19.44% | 15.08B | |
| +19.49% | 14.37B | |
| +57.58% | 13.06B | |
| -0.05% | 6.79B | |
| -9.70% | 6.75B | |
| -8.87% | 5.73B | |
| +13.66% | 5.64B | |
| +4.00% | 4.66B |
- Stock Market
- Equities
- MOLNRIPO Stock
